coronavirus infections/complications; coronavirus infections/therapy; COVID-19; SARS-CoV-2; pandemics; viral pneumonia; extracorporeal membrane oxygenation; acute respiratory distress syndrome/therapy
Critical Care | Virus Diseases
Coronavirus disease 2019 (COVID-19) may result in severe acute respiratory disease syndrome (ARDS) and death. For COVID-19 patients failing mechanical ventilation, extra corporeal membrane oxygenation (ECMO) has been used with varying efficacy in academic medical centers and quaternary referral centers. We report the successful use of veno-venous (VV) ECMO to treat refractory ARDS due to COVID-19 in a community hospital setting with a survival to discharge rate of 71% over a 3 month period. In a community hospital with adequate resources, VV ECMO can be an effective rescue therapy for selected COVID-19 patients who fail all other available treatments.
Loube, Daniel I.; Hassan, Kashif Z.; and Lee, Sang H.
"Extracorporeal Membrane Oxygenation for COVID-19 Treatment in a Community Hospital,"
HCA Healthcare Journal of Medicine: Vol. 1
, Article 10.
Available at: https://scholarlycommons.hcahealthcare.com/hcahealthcarejournal/vol1/iss0/10